New molecular challenges in CRC
Conclusions and clinical perspectives
Date
09 Oct 2016Session
New molecular challenges in CRCPresenters
Sabine TejparAuthors
S. TejparAuthor affiliations
- Digestive Oncology Unit, University Hospitals Leuven - Campus Gasthuisberg, 3000 - Leuven/BE
Resources
Login to access the resources on OncologyPRO.
If you do not have an ESMO account, please create one for free.
Resources from the same session
Patients with rare molecular alterations: Do they need a precision approach?
Presenter: Salvatore Siena
Session: New molecular challenges in CRC
Resources:
Slides
New classification of CRC: “Gone molecular”?
Presenter: Daniela Aust
Session: New molecular challenges in CRC
Resources:
Slides
Liquid biopsies: Ever closer to daily practice?
Presenter: Pierre Laurent-Puig
Session: New molecular challenges in CRC
Resources:
Slides
Introduction
Presenter: Per Pfeiffer
Session: New molecular challenges in CRC
Resources:
Slides
Immunotherapy in mCRC: MSI and beyond
Presenter: Neil Segal
Session: New molecular challenges in CRC
Resources:
Slides
BRAF mutations: What are the treatment options?
Presenter: Fotios Loupakis
Session: New molecular challenges in CRC
Resources:
Slides
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
-
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.